Endogenous IFN lambda in Viral Hepatitis Patients

Rik Groen, F Mcphee, J Friborg, HLA Janssen, Andre Boonstra

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)


Besides type I interferons (IFNs), type III IFNs, including IFN lambda 1 (interleukin-29 [IL-29]), possess potent antiviral activity. In patients infected with the hepatitis C virus (HCV), it has been demonstrated that viral clearance is associated with genetic variation near the IFN lambda 3 (IL-28B) gene. The rapid influx of research being conducted on this family of cytokines has led to several inconsistencies and controversies, including the possible correlation of serum cytokine levels with disease in chronic viral hepatitis patients. In a detailed study, well-characterized cohorts of patients with HBV and HCV were evaluated with 3 different immunoassays, and no differences in the levels of serum IFN lambda were observed between patient groups, disease stages, or clinical parameters.
Original languageUndefined/Unknown
Pages (from-to)552-556
Number of pages5
JournalJournal of Interferon and Cytokine Research
Issue number7
Publication statusPublished - 2014

Research programs

  • EMC MM-04-20-01
  • EMC MM-04-20-02-A

Cite this